Key result
Genetically instrumented higher serum iron was causally associated with an increased risk of atrial fibrillation (OR 1.09).
Why the study?
Observational links between iron status and atrial fibrillation may be biased by confounding and reverse causality, leaving a potential causal relationship unconfirmed.
Does genetically determined higher systemic iron status increase the risk of atrial fibrillation?
Observational (n=588,190)
Mendelian randomization
Yes
Does genetically determined higher systemic iron status increase the risk of atrial fibrillation?
Odds Ratio: 1.09 (95% CI 1.02–1.16)
p-value: p=0.01
Genetically determined higher systemic iron status is causally associated with an increased risk of atrial fibrillation, suggesting iron metabolism as a potential target for AF prevention.
Suggests iron as potential AF risk factor; hypothesis-generating and should not yet change practice.
Background Atrial fibrillation is the most common arrhythmia disease.Animal and observational studies have found a link between iron status and atrial fibrillation. However, the causal relationship between iron status and the risk of atrial fibrillation may be biased by confounding and reverse causality.The purpose of this investigation was to use Mendelian randomization (MR) analysis, which has been widely appied to estimate the causal effect,to reveal whether systemic iron status was causally related to atrial fibrillation. Methods Single nucleotide polymorphisms (SNPs) strongly associated (P < 5×10 −8 ) with four biomarkers of systemic iron status were obtained from a genome-wide association study involving 48,972 subjects conducted by the Genetics of Iron Status consortium. Summary-level data for the genetic associations with atrial fibrillation were acquired from AFGen (Atrial Fibrillation Genetics) consortium study(including 65,446 atrial fibrillation cases and 522,744 controls). We used a two-sample MR analysis to obtain a causal estimate, and further verified credibility through sensitivity analysis. Results Genetically instrumented serum iron [OR:1.09;95%; confidence interval (CI)1.02-1.16; p =0.01], ferritin [OR:1.16;95%CI:1.02-1.33; p =0.02], and transferrin saturation [OR:1.05;95%CI:1.01-1.11; p =0.01] had positive effects on atrial fibrillation. Genetically instrumented transferrin levels [OR:0.90;95%CI:0.86-0.97; p =0.006] was an inverse correlation with atrial fibrillation. Conclusion In conclusion,our results strongly elucidated a causal link between genetically determined higher iron status and increased the risk of atrial fibrillation.This provided new ideas for clinical prevention and treatment of atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2021) conducted an observational in Atrial fibrillation (n=588,190). Genetically instrumented higher serum iron vs. Genetically instrumented lower serum iron was evaluated on Atrial fibrillation (OR 1.09, 95% CI 1.02-1.16, p=0.01). Genetically instrumented higher serum iron was causally associated with an increased risk of atrial fibrillation (OR 1.09).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: